SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


SCHEDULE 13G/A
(Rule 13d-102)


Amendment No. 2

INFORMATION TO BE INCLUDED IN STATEMENTS PURSUANT TO RULES 13d-1(b), (c)

AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2 UNDER THE

SECURITIES EXCHANGE ACT OF 1934

ELITE PHARMACEUTICALS, INC.
(Name of Issuer)

COMMON STOCK, $0.01 PAR VALUE PER SHARE
(Title of Class of Securities)

28659T200
(CUSIP Number)

December 31, 2008
(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

[ ] Rule 13d-1(b)

[X] Rule 13d-1(c)

[ ] Rule 13d-1(d)


* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 (the "Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes)


Schedule 13G/A

CUSIP No. 28659T200 PAGE 2 OF 47

------------------------------------------------------------------------------
(1) NAME OF REPORTING PERSON
 S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
 Davidson Kempner Partners
------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
 (a) [ ]
 (b) [X]
------------------------------------------------------------------------------
(3) SEC USE ONLY
------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
 New York
------------------------------------------------------------------------------

NUMBER OF (5) SOLE VOTING POWER
 0
SHARES ____________________________________________________________
BENEFICIALLY (6) SHARED VOTING POWER
 309 Series C 8% Preferred Stock convertible into
 133,190 Common Shares, Warrants exercisable
 into 39,956 Common Shares and 81,300 Common Shares
OWNED BY ____________________________________________________________

EACH (7) SOLE DISPOSITIVE POWER
 0
REPORTING ____________________________________________________________
PERSON WITH (8) SHARED DISPOSITIVE POWER
 309 Series C 8% Preferred Stock convertible into
 133,190 Common Shares, Warrants exercisable
 into 39,956 Common Shares and 81,300 Common Shares
------------------------------------------------------------------------------
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED
 BY EACH REPORTING PERSON
 309 Series C 8% Preferred Stock convertible into 133,190
 Common Shares, Warrants exercisable into 39,956 Common
 Shares and 81,300 Common Shares
------------------------------------------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT
 IN ROW (9) EXCLUDES CERTAIN SHARES [ ]
------------------------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED
 BY AMOUNT IN ROW (9)
 0.8%
------------------------------------------------------------------------------
(12) TYPE OF REPORTING PERSON
 PN
------------------------------------------------------------------------------


Schedule 13G/A

CUSIP No. 28659T200 PAGE 3 OF 47

------------------------------------------------------------------------------
(1) NAME OF REPORTING PERSON
 S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
 Davidson Kempner Institutional Partners, L.P.
------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
 (a) [ ]
 (b) [X]
------------------------------------------------------------------------------
(3) SEC USE ONLY
------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
 Delaware
------------------------------------------------------------------------------

NUMBER OF (5) SOLE VOTING POWER
 0
SHARES ____________________________________________________________
BENEFICIALLY (6) SHARED VOTING POWER
 560 Series C 8% Preferred Stock convertible into
 241,379 Common Shares, Warrants exercisable
 into 72,412 Common Shares and 147,462 Common Shares
OWNED BY ____________________________________________________________

EACH (7) SOLE DISPOSITIVE POWER
 0
REPORTING ____________________________________________________________
PERSON WITH (8) SHARED DISPOSITIVE POWER
 560 Series C 8% Preferred Stock convertible into
 241,379 Common Shares, Warrants exercisable
 into 72,412 Common Shares and 147,462 Common Shares
------------------------------------------------------------------------------
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED
 BY EACH REPORTING PERSON
 560 Series C 8% Preferred Stock convertible into 241,379
 Common Shares, Warrants exercisable into 72,412 Common
 Shares and 147,462 Common Shares
------------------------------------------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT
 IN ROW (9) EXCLUDES CERTAIN SHARES [ ]
------------------------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED
 BY AMOUNT IN ROW (9)
 1.4%
------------------------------------------------------------------------------
(12) TYPE OF REPORTING PERSON
 PN
------------------------------------------------------------------------------


Schedule 13G/A

CUSIP No. 28659T200 PAGE 4 OF 47

------------------------------------------------------------------------------
(1) NAME OF REPORTING PERSON
 S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
 M. H. Davidson & Co.
------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
 (a) [ ]
 (b) [X]
------------------------------------------------------------------------------
(3) SEC USE ONLY
------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
 New York
------------------------------------------------------------------------------

NUMBER OF (5) SOLE VOTING POWER
 0
SHARES ____________________________________________________________
BENEFICIALLY (6) SHARED VOTING POWER
 40 Series C 8% Preferred Stock convertible into
 17,241 Common Shares, Warrants exercisable into
 5,172 Common Shares and 10,548 Common Shares
OWNED BY ____________________________________________________________

EACH (7) SOLE DISPOSITIVE POWER
 0
REPORTING ____________________________________________________________
PERSON WITH (8) SHARED DISPOSITIVE POWER
 40 Series C 8% Preferred Stock convertible into
 17,241 Common Shares, Warrants exercisable
 into 5,172 Common Shares and 10,548 Common Shares
------------------------------------------------------------------------------
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED
 BY EACH REPORTING PERSON
 40 Series C 8% Preferred Stock convertible into 17,241 Common
 Shares, Warrants exercisable into 5,172 Common Shares
 and 10,548 Common Shares
------------------------------------------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT
 IN ROW (9) EXCLUDES CERTAIN SHARES [ ]
------------------------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED
 BY AMOUNT IN ROW (9)
 0.1%
------------------------------------------------------------------------------
(12) TYPE OF REPORTING PERSON
 PN
------------------------------------------------------------------------------


Schedule 13G/A

CUSIP No. 28659T200 PAGE 5 OF 47

------------------------------------------------------------------------------
(1) NAME OF REPORTING PERSON
 S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
 Davidson Kempner International, Ltd.
------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
 (a) [ ]
 (b) [X]
------------------------------------------------------------------------------
(3) SEC USE ONLY
------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
 British Virgin Islands
------------------------------------------------------------------------------

NUMBER OF (5) SOLE VOTING POWER
 0
SHARES ____________________________________________________________
BENEFICIALLY (6) SHARED VOTING POWER
 1,007 Series C 8% Preferred Stock convertible into
 434,052 Common Shares, Warrants exercisable
 into 130,213 Common Shares and 265,154 Common Shares
OWNED BY ____________________________________________________________

EACH (7) SOLE DISPOSITIVE POWER
 0
REPORTING ____________________________________________________________
PERSON WITH (8) SHARED DISPOSITIVE POWER
 1,007 Series C 8% Preferred Stock convertible into
 434,052 Common Shares, Warrants exercisable
 into 130,213 Common Shares and 265,154 Common Shares
------------------------------------------------------------------------------
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED
 BY EACH REPORTING PERSON
 1,007 Series C 8% Preferred Stock convertible into 434,052 Common
 Shares, Warrants exercisable into 130,213 Common Shares and
 265,154 Common Shares
------------------------------------------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT
 IN ROW (9) EXCLUDES CERTAIN SHARES [ ]
------------------------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED
 BY AMOUNT IN ROW (9)
 2.5%
------------------------------------------------------------------------------
(12) TYPE OF REPORTING PERSON
 CO
------------------------------------------------------------------------------


Schedule 13G/A

CUSIP No. 28659T200 PAGE 6 OF 47

------------------------------------------------------------------------------
(1) NAME OF REPORTING PERSON
 S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
 Serena Limited
------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
 (a) [ ]
 (b) [X]
------------------------------------------------------------------------------
(3) SEC USE ONLY
------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
 Cayman Islands
------------------------------------------------------------------------------

NUMBER OF (5) SOLE VOTING POWER
 0
SHARES ____________________________________________________________
BENEFICIALLY (6) SHARED VOTING POWER
 0

OWNED BY ____________________________________________________________

EACH (7) SOLE DISPOSITIVE POWER
 0
REPORTING ____________________________________________________________
PERSON WITH (8) SHARED DISPOSITIVE POWER
 0

------------------------------------------------------------------------------
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED
 BY EACH REPORTING PERSON
 0

------------------------------------------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT
 IN ROW (9) EXCLUDES CERTAIN SHARES [ ]
------------------------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED
 BY AMOUNT IN ROW (9)
 0.0%
------------------------------------------------------------------------------
(12) TYPE OF REPORTING PERSON
 CO
------------------------------------------------------------------------------


Schedule 13G/A

CUSIP No. 28659T200 PAGE 7 OF 47

------------------------------------------------------------------------------
(1) NAME OF REPORTING PERSON
 S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
 Davidson Kempner Healthcare Fund LP
------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
 (a) [ ]
 (b) [X]
------------------------------------------------------------------------------
(3) SEC USE ONLY
------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
 Delaware
------------------------------------------------------------------------------

NUMBER OF (5) SOLE VOTING POWER
 0
SHARES ____________________________________________________________
BENEFICIALLY (6) SHARED VOTING POWER
 2,449 Series C 8% Preferred Stock convertible into
 1,055,603 Common Shares, Warrants exercisable
 into 316,680 Common Shares and 648,953 Common Shares
OWNED BY ____________________________________________________________

EACH (7) SOLE DISPOSITIVE POWER
 0
REPORTING ____________________________________________________________

PERSON WITH (8) SHARED DISPOSITIVE POWER
 2,449 Series C 8% Preferred Stock convertible into
 1,055,603 Common Shares, Warrants exercisable
 into 316,680 Common Shares and 648,953 Common Shares
------------------------------------------------------------------------------
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED
 BY EACH REPORTING PERSON
 2,449 Series C 8% Preferred Stock convertible into 1,055,603
 Common Shares, Warrants exercisable into 316,680
 Common Shares and 648,953 Common Shares
------------------------------------------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT
 IN ROW (9) EXCLUDES CERTAIN SHARES [ ]
------------------------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED
 BY AMOUNT IN ROW (9)
 6.0%
------------------------------------------------------------------------------
(12) TYPE OF REPORTING PERSON
 PN

------------------------------------------------------------------------------


Schedule 13G/A

CUSIP No. 28659T200 PAGE 8 OF 47

------------------------------------------------------------------------------
(1) NAME OF REPORTING PERSON
 S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
 Davidson Kempner
 Healthcare International Ltd.
------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
 (a) [ ]
 (b) [X]

------------------------------------------------------------------------------
(3) SEC USE ONLY
------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
 Cayman Islands
------------------------------------------------------------------------------

NUMBER OF (5) SOLE VOTING POWER
 0
SHARES ____________________________________________________________

BENEFICIALLY (6) SHARED VOTING POWER
 3,602 Series C 8% Preferred Stock convertible into
 1,552,586 Common Shares, Warrants exercisable
 into 465,775 Common Shares and 954,832 Common Shares
OWNED BY ____________________________________________________________

EACH (7) SOLE DISPOSITIVE POWER
 0
REPORTING ____________________________________________________________
PERSON WITH (8) SHARED DISPOSITIVE POWER
 3,602 Series C 8% Preferred Stock convertible into
 1,552,586 Common Shares, Warrants exercisable
 into 465,775 Common Shares and 954,832 Common Shares
------------------------------------------------------------------------------
 (9) AGGREGATE AMOUNT BENEFICIALLY OWNED
 BY EACH REPORTING PERSON
 3,602 Series C 8% Preferred Stock convertible into 1,552,586
 Common Shares, Warrants exercisable into 465,775
 Common Shares and 954,832 Common Shares
------------------------------------------------------------------------------
 (10) CHECK BOX IF THE AGGREGATE AMOUNT
 IN ROW (9) EXCLUDES CERTAIN SHARES [ ]
------------------------------------------------------------------------------
 (11) PERCENT OF CLASS REPRESENTED
 BY AMOUNT IN ROW (9)
 8.8%
------------------------------------------------------------------------------
 (12) TYPE OF REPORTING PERSON
 CO

------------------------------------------------------------------------------


Schedule 13G/A

CUSIP No. 28659T200 PAGE 9 OF 47

------------------------------------------------------------------------------
(1) NAME OF REPORTING PERSON
 S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
 MHD Management Co.
------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
 (a) [ ]
 (b) [X]

------------------------------------------------------------------------------
(3) SEC USE ONLY
------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
 New York
------------------------------------------------------------------------------

NUMBER OF (5) SOLE VOTING POWER
 0
SHARES ____________________________________________________________
BENEFICIALLY (6) SHARED VOTING POWER
 309 Series C 8% Preferred Stock convertible into
 133,190 Common Shares, Warrants exercisable
 into 39,956 Common Shares and 81,300 Common Shares
OWNED BY ____________________________________________________________

EACH (7) SOLE DISPOSITIVE POWER
 0
REPORTING ____________________________________________________________
PERSON WITH (8) SHARED DISPOSITIVE POWER
 309 Series C 8% Preferred Stock convertible into
 133,190 Common Shares, Warrants exercisable
 into 39,956 Common Shares and 81,300 Common Shares
------------------------------------------------------------------------------
 (9) AGGREGATE AMOUNT BENEFICIALLY OWNED
 BY EACH REPORTING PERSON
 309 Series C 8% Preferred Stock convertible into 133,190
 Common Shares, Warrants exercisable into 39,956 Common
 Shares and 81,300 Common Shares
------------------------------------------------------------------------------
 (10) CHECK BOX IF THE AGGREGATE AMOUNT
 IN ROW (9) EXCLUDES CERTAIN SHARES [ ]
------------------------------------------------------------------------------
 (11) PERCENT OF CLASS REPRESENTED
 BY AMOUNT IN ROW (9)
 0.8%
------------------------------------------------------------------------------
 (12) TYPE OF REPORTING PERSON
 PN

------------------------------------------------------------------------------


Schedule 13G/A

CUSIP No. 28659T200 PAGE 10 OF 47

------------------------------------------------------------------------------
(1) NAME OF REPORTING PERSON
 S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
 Davidson Kempner Advisers Inc.
------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
 (a) [ ]
 (b) [X]

------------------------------------------------------------------------------
(3) SEC USE ONLY
------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
 New York
------------------------------------------------------------------------------

NUMBER OF (5) SOLE VOTING POWER
 0
SHARES ____________________________________________________________
BENEFICIALLY (6) SHARED VOTING POWER
 560 Series C 8% Preferred Stock convertible into
 241,379 Common Shares, Warrants exercisable
 into 72,412 Common Shares and 147,462 Common Shares
OWNED BY ____________________________________________________________

EACH (7) SOLE DISPOSITIVE POWER
 0
REPORTING ____________________________________________________________
PERSON WITH (8) SHARED DISPOSITIVE POWER
 560 Series C 8% Preferred Stock convertible into
 241,379 Common Shares, Warrants exercisable
 into 72,412 Common Shares and 147,462 Common Shares
------------------------------------------------------------------------------
 (9) AGGREGATE AMOUNT BENEFICIALLY OWNED
 BY EACH REPORTING PERSON
 560 Series C 8% Preferred Stock convertible into 241,379
 Common Shares, Warrants exercisable into 72,412 Common
 Shares and 147,462 Common Shares
------------------------------------------------------------------------------
 (10) CHECK BOX IF THE AGGREGATE AMOUNT
 IN ROW (9) EXCLUDES CERTAIN SHARES [ ]
------------------------------------------------------------------------------
 (11) PERCENT OF CLASS REPRESENTED
 BY AMOUNT IN ROW (9)
 1.4%
------------------------------------------------------------------------------
 (12) TYPE OF REPORTING PERSON
 IA

------------------------------------------------------------------------------


Schedule 13G/A

CUSIP No. 28659T200 PAGE 11 OF 47

------------------------------------------------------------------------------
(1) NAME OF REPORTING PERSON
 S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
 Davidson Kempner International Advisors, L.L.C.
------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
 (a) [ ]
 (b) [X]

------------------------------------------------------------------------------
(3) SEC USE ONLY
------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
 Delaware
------------------------------------------------------------------------------

NUMBER OF (5) SOLE VOTING POWER
 0
SHARES ____________________________________________________________
BENEFICIALLY (6) SHARED VOTING POWER
 1,007 Series C 8% Preferred Stock convertible into
 434,052 Common Shares, Warrants exercisable
 into 130,213 Common Shares and 265,154 Common Shares
OWNED BY ____________________________________________________________

EACH (7) SOLE DISPOSITIVE POWER
 0
REPORTING ____________________________________________________________
PERSON WITH (8) SHARED DISPOSITIVE POWER
 1,007 Series C 8% Preferred Stock convertible into
 434,052 Common Shares, Warrants exercisable
 into 130,213 Common Shares and 265,154 Common Shares
------------------------------------------------------------------------------
 (9) AGGREGATE AMOUNT BENEFICIALLY OWNED
 BY EACH REPORTING PERSON
 1,007 Series C 8% Preferred Stock convertible into 434,052
 Common Shares, Warrants exercisable into 130,213
 Common Shares and 265,154 Common Shares
------------------------------------------------------------------------------
 (10) CHECK BOX IF THE AGGREGATE AMOUNT
 IN ROW (9) EXCLUDES CERTAIN SHARES [ ]
------------------------------------------------------------------------------
 (11) PERCENT OF CLASS REPRESENTED
 BY AMOUNT IN ROW (9)
 2.5%
------------------------------------------------------------------------------
 (12) TYPE OF REPORTING PERSON
 OO
------------------------------------------------------------------------------


Schedule 13G/A

CUSIP No. 28659T200 PAGE 12 OF 47

------------------------------------------------------------------------------
(1) NAME OF REPORTING PERSON
 S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
 DK Group LLC
------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
 (a) [ ]
 (b) [X]

------------------------------------------------------------------------------
(3) SEC USE ONLY
------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
 Delaware
------------------------------------------------------------------------------

NUMBER OF (5) SOLE VOTING POWER
 0
SHARES ____________________________________________________________
BENEFICIALLY (6) SHARED VOTING POWER
 2,449 Series C 8% Preferred Stock convertible into
 1,055,603 Common Shares, Warrants exercisable
 into 316,680 Common Shares and 648,953 Common Shares
OWNED BY ____________________________________________________________

EACH (7) SOLE DISPOSITIVE POWER
 0
REPORTING ____________________________________________________________
PERSON WITH (8) SHARED DISPOSITIVE POWER
 2,449 Series C 8% Preferred Stock convertible into
 1,055,603 Common Shares, Warrants exercisable
 into 316,680 Common Shares and 648,953 Common Shares
------------------------------------------------------------------------------
 (9) AGGREGATE AMOUNT BENEFICIALLY OWNED
 BY EACH REPORTING PERSON
 2,449 Series C 8% Preferred Stock convertible into 1,055,603
 Common Shares, Warrants exercisable into 316,680
 Common Shares and 648,953 Common Shares
------------------------------------------------------------------------------
 (10) CHECK BOX IF THE AGGREGATE AMOUNT
 IN ROW (9) EXCLUDES CERTAIN SHARES [ ]
------------------------------------------------------------------------------
 (11) PERCENT OF CLASS REPRESENTED
 BY AMOUNT IN ROW (9)
 6.0%
------------------------------------------------------------------------------
 (12) TYPE OF REPORTING PERSON
 OO
------------------------------------------------------------------------------


Schedule 13G/A

CUSIP No. 28659T200 PAGE 13 OF 47

------------------------------------------------------------------------------
(1) NAME OF REPORTING PERSON
 S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
 DK Management Partners LP
------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
 (a) [ ]
 (b) [X]

------------------------------------------------------------------------------
(3) SEC USE ONLY
------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
 Delaware
------------------------------------------------------------------------------

NUMBER OF (5) SOLE VOTING POWER
 0
SHARES _____________________________________________________________
BENEFICIALLY (6) SHARED VOTING POWER
 3,602 Series C 8% Preferred Stock convertible into
 1,552,586 Common Shares, Warrants exercisable
 into 465,775 Common Shares and 954,832 Common Shares
OWNED BY _____________________________________________________________

EACH (7) SOLE DISPOSITIVE POWER
 0
REPORTING ____________________________________________________________
PERSON WITH (8) SHARED DISPOSITIVE POWER
 3,602 Series C 8% Preferred Stock convertible into
 1,552,586 Common Shares, Warrants exercisable
 into 465,775 Common Shares and 954,832 Common Shares
------------------------------------------------------------------------------
 (9) AGGREGATE AMOUNT BENEFICIALLY OWNED
 BY EACH REPORTING PERSON
 3,602 Series C 8% Preferred Stock convertible into 1,552,586
 Common Shares, Warrants exercisable into 465,775
 Common Shares and 954,832 Common Shares
------------------------------------------------------------------------------
 (10) CHECK BOX IF THE AGGREGATE AMOUNT
 IN ROW (9) EXCLUDES CERTAIN SHARES [ ]
------------------------------------------------------------------------------
 (11) PERCENT OF CLASS REPRESENTED
 BY AMOUNT IN ROW (9)
 8.8%
------------------------------------------------------------------------------
 (12) TYPE OF REPORTING PERSON
 PN
------------------------------------------------------------------------------


Schedule 13G/A

CUSIP No. 28659T200 PAGE 14 OF 47

------------------------------------------------------------------------------
(1) NAME OF REPORTING PERSON
 S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
 DK Stillwater GP LLC
------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
 (a) [ ]
 (b) [X]

------------------------------------------------------------------------------
(3) SEC USE ONLY
------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
 Delaware
------------------------------------------------------------------------------

NUMBER OF (5) SOLE VOTING POWER
 0
SHARES ____________________________________________________________
BENEFICIALLY (6) SHARED VOTING POWER
 3,602 Series C 8% Preferred Stock convertible into
 1,552,586 Common Shares, Warrants exercisable
 into 465,775 Common Shares and 954,832 Common Shares
OWNED BY ____________________________________________________________

EACH (7) SOLE DISPOSITIVE POWER
 0
REPORTING ____________________________________________________________
PERSON WITH (8) SHARED DISPOSITIVE POWER
 3,602 Series C 8% Preferred Stock convertible into
 1,552,586 Common Shares, Warrants exercisable
 into 465,775 Common Shares and 954,832 Common Shares
------------------------------------------------------------------------------
 (9) AGGREGATE AMOUNT BENEFICIALLY OWNED
 BY EACH REPORTING PERSON
 3,602 Series C 8% Preferred Stock convertible into 1,552,586
 Common Shares, Warrants exercisable into 465,775
 Common Shares and 954,832 Common Shares
______________________________________________________________________________
 (10) CHECK BOX IF THE AGGREGATE AMOUNT
 IN ROW (9) EXCLUDES CERTAIN SHARES [ ]
------------------------------------------------------------------------------
 (11) PERCENT OF CLASS REPRESENTED
 BY AMOUNT IN ROW (9)
 8.8%
------------------------------------------------------------------------------
 (12) TYPE OF REPORTING PERSON
 OO
------------------------------------------------------------------------------


Schedule 13G/A

CUSIP No. 28659T200 PAGE 15 OF 47

------------------------------------------------------------------------------
(1) NAME OF REPORTING PERSON
 S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
 Thomas L. Kempner, Jr.
------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
 (a) [ ]
 (b) [X]

------------------------------------------------------------------------------
(3) SEC USE ONLY
------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
 United States
------------------------------------------------------------------------------

NUMBER OF (5) SOLE VOTING POWER
 0
SHARES ____________________________________________________________
BENEFICIALLY (6) SHARED VOTING POWER
 7,967 Series C 8% Preferred Stock convertible into
 3,434,052 Common Shares, Warrants exercisable into
 1,030,208 Common Shares and 2,108,249 Common Shares
OWNED BY ____________________________________________________________
EACH (7) SOLE DISPOSITIVE POWER
 0
REPORTING ____________________________________________________________
PERSON WITH (8) SHARED DISPOSITIVE POWER
 7,967 Series C 8% Preferred Stock convertible into
 3,434,052 Common Shares, Warrants exercisable into
 1,030,208 Common Shares and 2,108,249 Common Shares
------------------------------------------------------------------------------
 (9) AGGREGATE AMOUNT BENEFICIALLY OWNED
 BY EACH REPORTING PERSON
 7,967 Series C 8% Preferred Stock convertible into
 3,434,052 Common Shares, Warrants exercisable into
 1,030,208 Common Shares and 2,108,249 Common Shares
------------------------------------------------------------------------------
 (10) CHECK BOX IF THE AGGREGATE AMOUNT
 IN ROW (9) EXCLUDES CERTAIN SHARES [ ]
------------------------------------------------------------------------------
 (11) PERCENT OF CLASS REPRESENTED
 BY AMOUNT IN ROW (9)
 9.9%(1)
------------------------------------------------------------------------------
 (12) TYPE OF REPORTING PERSON
 IN
------------------------------------------------------------------------------

---------------------
(1) Subject to the Ownership Limitation (as defined herein).


Schedule 13G/A

CUSIP No. 28659T200 PAGE 16 OF 47

------------------------------------------------------------------------------
(1) NAME OF REPORTING PERSON
 S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
 Marvin H. Davidson
------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
 (a) [ ]
 (b) [X]

------------------------------------------------------------------------------
(3) SEC USE ONLY
------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
 United States
------------------------------------------------------------------------------
NUMBER OF (5) SOLE VOTING POWER
 0
SHARES ____________________________________________________________
BENEFICIALLY (6) SHARED VOTING POWER
 7,967 Series C 8% Preferred Stock convertible into
 3,434,052 Common Shares, Warrants exercisable into
 1,030,208 Common Shares and 2,108,249 Common Shares
OWNED BY ____________________________________________________________
EACH (7) SOLE DISPOSITIVE POWER
 0
REPORTING ____________________________________________________________
PERSON WITH (8) SHARED DISPOSITIVE POWER
 7,967 Series C 8% Preferred Stock convertible into
 3,434,052 Common Shares, Warrants exercisable into
 1,030,208 Common Shares and 2,108,249 Common Shares
------------------------------------------------------------------------------
 (9) AGGREGATE AMOUNT BENEFICIALLY OWNED
 BY EACH REPORTING PERSON
 7,967 Series C 8% Preferred Stock convertible into
 3,434,052 Common Shares, Warrants exercisable into
 1,030,208 Common Shares and 2,108,249 Common Shares
------------------------------------------------------------------------------
 (10) CHECK BOX IF THE AGGREGATE AMOUNT
 IN ROW (9) EXCLUDES CERTAIN SHARES [ ]
------------------------------------------------------------------------------
 (11) PERCENT OF CLASS REPRESENTED
 BY AMOUNT IN ROW (9)
 9.9%(2)
------------------------------------------------------------------------------
 (12) TYPE OF REPORTING PERSON
 IN

------------------------------------------------------------------------------

---------------------
(2) Subject to the Ownership Limitation (as defined herein).


Schedule 13G/A

CUSIP No. 28659T200 PAGE 17 OF 47

------------------------------------------------------------------------------
(1) NAME OF REPORTING PERSON
 S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
 Stephen M. Dowicz
------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
 (a) [ ]
 (b) [X]

------------------------------------------------------------------------------
(3) SEC USE ONLY
------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
 United States
------------------------------------------------------------------------------
NUMBER OF (5) SOLE VOTING POWER
 0
SHARES ____________________________________________________________
BENEFICIALLY (6) SHARED VOTING POWER
 7,967 Series C 8% Preferred Stock convertible into
 3,434,052 Common Shares, Warrants exercisable into
 1,030,208 Common Shares and 2,108,249 Common Shares
OWNED BY ____________________________________________________________
EACH (7) SOLE DISPOSITIVE POWER
 0
REPORTING ____________________________________________________________
PERSON WITH (8) SHARED DISPOSITIVE POWER
 7,967 Series C 8% Preferred Stock convertible into
 3,434,052 Common Shares, Warrants exercisable into
 1,030,208 Common Shares and 2,108,249 Common Shares
------------------------------------------------------------------------------
 (9) AGGREGATE AMOUNT BENEFICIALLY OWNED
 BY EACH REPORTING PERSON
 7,967 Series C 8% Preferred Stock convertible into
 3,434,052 Common Shares, Warrants exercisable into
 1,030,208 Common Shares and 2,108,249 Common Shares
------------------------------------------------------------------------------
 (10) CHECK BOX IF THE AGGREGATE AMOUNT
 IN ROW (9) EXCLUDES CERTAIN SHARES [ ]
------------------------------------------------------------------------------
 (11) PERCENT OF CLASS REPRESENTED
 BY AMOUNT IN ROW (9)
 9.9%(3)
------------------------------------------------------------------------------
 (12) TYPE OF REPORTING PERSON
 IN
------------------------------------------------------------------------------

---------------------
(3) Subject to the Ownership Limitation (as defined herein).


Schedule 13G/A

CUSIP No. 28659T200 PAGE 18 OF 47

------------------------------------------------------------------------------
(1) NAME OF REPORTING PERSON
 S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
 Scott E. Davidson
------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
 (a) [ ]
 (b) [X]

------------------------------------------------------------------------------
(3) SEC USE ONLY
------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
 United States
------------------------------------------------------------------------------
NUMBER OF (5) SOLE VOTING POWER
 0
SHARES ____________________________________________________________
BENEFICIALLY (6) SHARED VOTING POWER
 7,967 Series C 8% Preferred Stock convertible into
 3,434,052 Common Shares, Warrants exercisable into
 1,030,208 Common Shares and 2,108,249 Common Shares
OWNED BY ____________________________________________________________
EACH (7) SOLE DISPOSITIVE POWER
 0
REPORTING ____________________________________________________________
PERSON WITH (8) SHARED DISPOSITIVE POWER
 7,967 Series C 8% Preferred Stock convertible into
 3,434,052 Common Shares, Warrants exercisable into
 1,030,208 Common Shares and 2,108,249 Common Shares
------------------------------------------------------------------------------
 (9) AGGREGATE AMOUNT BENEFICIALLY OWNED
 BY EACH REPORTING PERSON
 7,967 Series C 8% Preferred Stock convertible into
 3,434,052 Common Shares, Warrants exercisable into
 1,030,208 Common Shares and 2,108,249 Common Shares
------------------------------------------------------------------------------
 (10) CHECK BOX IF THE AGGREGATE AMOUNT
 IN ROW (9) EXCLUDES CERTAIN SHARES [ ]
------------------------------------------------------------------------------
 (11) PERCENT OF CLASS REPRESENTED
 BY AMOUNT IN ROW (9)
 9.9%(4)
------------------------------------------------------------------------------
 (12) TYPE OF REPORTING PERSON
 IN
------------------------------------------------------------------------------

---------------------
(4) Subject to the Ownership Limitation (as defined herein).


Schedule 13G/A

CUSIP No. 28659T200 PAGE 19 OF 47

------------------------------------------------------------------------------
(1) NAME OF REPORTING PERSON
 S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
 Michael J. Leffell
------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
 (a) [ ]
 (b) [X]

------------------------------------------------------------------------------
(3) SEC USE ONLY
------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
 United States
------------------------------------------------------------------------------
NUMBER OF (5) SOLE VOTING POWER
 0
SHARES ____________________________________________________________
BENEFICIALLY (6) SHARED VOTING POWER
 7,967 Series C 8% Preferred Stock convertible into
 3,434,052 Common Shares, Warrants exercisable into
 1,030,208 Common Shares and 2,108,249 Common Shares
OWNED BY ____________________________________________________________
EACH 7) SOLE DISPOSITIVE POWER
 0
REPORTING ____________________________________________________________
PERSON WITH (8) SHARED DISPOSITIVE POWER
 7,967 Series C 8% Preferred Stock convertible into
 3,434,052 Common Shares, Warrants exercisable into
 1,030,208 Common Shares and 2,108,249 Common Shares
------------------------------------------------------------------------------
 (9) AGGREGATE AMOUNT BENEFICIALLY OWNED
 BY EACH REPORTING PERSON
 7,967 Series C 8% Preferred Stock convertible into
 3,434,052 Common Shares, Warrants exercisable into
 1,030,208 Common Shares and 2,108,249 Common Shares
------------------------------------------------------------------------------
 (10) CHECK BOX IF THE AGGREGATE AMOUNT
 IN ROW (9) EXCLUDES CERTAIN SHARES [ ]
------------------------------------------------------------------------------
 (11) PERCENT OF CLASS REPRESENTED
 BY AMOUNT IN ROW (9)
 9.9%(5)
------------------------------------------------------------------------------
 (12) TYPE OF REPORTING PERSON
 IN
------------------------------------------------------------------------------

---------------------
(5) Subject to the Ownership Limitation (as defined herein).


Schedule 13G/A

CUSIP No. 28659T200 PAGE 20 OF 47

------------------------------------------------------------------------------
(1) NAME OF REPORTING PERSON
 S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
 Timothy I. Levart
------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
 (a) [ ]
 (b) [X]

------------------------------------------------------------------------------
(3) SEC USE ONLY
------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
 United Kingdom & United States
------------------------------------------------------------------------------
NUMBER OF (5) SOLE VOTING POWER
 0
SHARES ____________________________________________________________
BENEFICIALLY (6) SHARED VOTING POWER
 7,967 Series C 8% Preferred Stock convertible into
 3,434,052 Common Shares, Warrants exercisable into
 1,030,208 Common Shares and 2,108,249 Common Shares
OWNED BY ____________________________________________________________
EACH (7) SOLE DISPOSITIVE POWER
 0
REPORTING ____________________________________________________________
PERSON WITH (8) SHARED DISPOSITIVE POWER
 7,967 Series C 8% Preferred Stock convertible into
 3,434,052 Common Shares, Warrants exercisable into
 1,030,208 Common Shares and 2,108,249 Common Shares
------------------------------------------------------------------------------
 (9) AGGREGATE AMOUNT BENEFICIALLY OWNED
 BY EACH REPORTING PERSON
 7,967 Series C 8% Preferred Stock convertible into
 3,434,052 Common Shares, Warrants exercisable into
 1,030,208 Common Shares and 2,108,249 Common Shares
------------------------------------------------------------------------------
 (10) CHECK BOX IF THE AGGREGATE AMOUNT
 IN ROW (9) EXCLUDES CERTAIN SHARES [ ]
------------------------------------------------------------------------------
 (11) PERCENT OF CLASS REPRESENTED
 BY AMOUNT IN ROW (9)
 9.9%(6)
------------------------------------------------------------------------------
 (12) TYPE OF REPORTING PERSON
 IN

------------------------------------------------------------------------------

---------------------
(6) Subject to the Ownership Limitation (as defined herein).


Schedule 13G/A

CUSIP No. 28659T200 PAGE 21 OF 47

------------------------------------------------------------------------------
(1) NAME OF REPORTING PERSON
 S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
 Robert J. Brivio, Jr.
------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
 (a) [ ]
 (b) [X]

------------------------------------------------------------------------------
(3) SEC USE ONLY
------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
 United States
------------------------------------------------------------------------------
NUMBER OF (5) SOLE VOTING POWER
 0
SHARES ____________________________________________________________
BENEFICIALLY (6) SHARED VOTING POWER
 7,967 Series C 8% Preferred Stock convertible into
 3,434,052 Common Shares, Warrants exercisable into
 1,030,208 Common Shares and 2,108,249 Common Shares
OWNED BY ____________________________________________________________
EACH (7) SOLE DISPOSITIVE POWER
 0
REPORTING ____________________________________________________________
PERSON WITH (8) SHARED DISPOSITIVE POWER
 7,967 Series C 8% Preferred Stock convertible into
 3,434,052 Common Shares, Warrants exercisable into
 1,030,208 Common Shares and 2,108,249 Common Shares
------------------------------------------------------------------------------
 (9) AGGREGATE AMOUNT BENEFICIALLY OWNED
 BY EACH REPORTING PERSON
 7,967 Series C 8% Preferred Stock convertible into
 3,434,052 Common Shares, Warrants exercisable into
 1,030,208 Common Shares and 2,108,249 Common Shares
------------------------------------------------------------------------------
 (10) CHECK BOX IF THE AGGREGATE AMOUNT
 IN ROW (9) EXCLUDES CERTAIN SHARES [ ]
------------------------------------------------------------------------------
 (11) PERCENT OF CLASS REPRESENTED
 BY AMOUNT IN ROW (9)
 9.9%(7)
------------------------------------------------------------------------------
 (12) TYPE OF REPORTING PERSON
 IN
------------------------------------------------------------------------------

---------------------
(7) Subject to the Ownership Limitation (as defined herein).


Schedule 13G/A

CUSIP No. 28659T200 PAGE 22 OF 47

------------------------------------------------------------------------------
(1) NAME OF REPORTING PERSON
 S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
 Eric P. Epstein
------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
 (a) [ ]
 (b) [X]

------------------------------------------------------------------------------
(3) SEC USE ONLY
------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
 United States
------------------------------------------------------------------------------
NUMBER OF (5) SOLE VOTING POWER
 0
SHARES ____________________________________________________________
BENEFICIALLY (6) SHARED VOTING POWER
 7,967 Series C 8% Preferred Stock convertible into
 3,434,052 Common Shares, Warrants exercisable into
 1,030,208 Common Shares and 2,108,249 Common Shares
OWNED BY ____________________________________________________________
EACH (7) SOLE DISPOSITIVE POWER
 0
REPORTING ____________________________________________________________
PERSON WITH (8) SHARED DISPOSITIVE POWER
 7,967 Series C 8% Preferred Stock convertible into
 3,434,052 Common Shares, Warrants exercisable into
 1,030,208 Common Shares and 2,108,249 Common Shares
------------------------------------------------------------------------------
 (9) AGGREGATE AMOUNT BENEFICIALLY OWNED
 BY EACH REPORTING PERSON
 7,967 Series C 8% Preferred Stock convertible into
 3,434,052 Common Shares, Warrants exercisable into
 1,030,208 Common Shares and 2,108,249 Common Shares
------------------------------------------------------------------------------
 (10) CHECK BOX IF THE AGGREGATE AMOUNT
 IN ROW (9) EXCLUDES CERTAIN SHARES [ ]
------------------------------------------------------------------------------
 (11) PERCENT OF CLASS REPRESENTED
 BY AMOUNT IN ROW (9)
 9.9%(8)
------------------------------------------------------------------------------
 (12) TYPE OF REPORTING PERSON
 IN
------------------------------------------------------------------------------

---------------------
(8) Subject to the Ownership Limitation (as defined herein).


Schedule 13G/A

CUSIP No. 28659T200 PAGE 23 OF 47

------------------------------------------------------------------------------
(1) NAME OF REPORTING PERSON
 S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
 Anthony A. Yoseloff
------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
 (a) [ ]
 (b) [X]

------------------------------------------------------------------------------
(3) SEC USE ONLY
------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
 United States
------------------------------------------------------------------------------
NUMBER OF (5) SOLE VOTING POWER
 0
SHARES ____________________________________________________________
BENEFICIALLY (6) SHARED VOTING POWER
 7,967 Series C 8% Preferred Stock convertible into
 3,434,052 Common Shares, Warrants exercisable into
 1,030,208 Common Shares and 2,108,249 Common Shares
OWNED BY ____________________________________________________________
EACH (7) SOLE DISPOSITIVE POWER
 0
REPORTING ____________________________________________________________
PERSON WITH (8) SHARED DISPOSITIVE POWER
 7,967 Series C 8% Preferred Stock convertible into
 3,434,052 Common Shares, Warrants exercisable into
 1,030,208 Common Shares and 2,108,249 Common Shares
------------------------------------------------------------------------------
 (9) AGGREGATE AMOUNT BENEFICIALLY OWNED
 BY EACH REPORTING PERSON
 7,967 Series C 8% Preferred Stock convertible into
 3,434,052 Common Shares, Warrants exercisable into
 1,030,208 Common Shares and 2,108,249 Common Shares
------------------------------------------------------------------------------
 (10) CHECK BOX IF THE AGGREGATE AMOUNT
 IN ROW (9) EXCLUDES CERTAIN SHARES [ ]
------------------------------------------------------------------------------
 (11) PERCENT OF CLASS REPRESENTED
 BY AMOUNT IN ROW (9)
 9.9%(9)
------------------------------------------------------------------------------
 (12) TYPE OF REPORTING PERSON
 IN
------------------------------------------------------------------------------

---------------------
(9) Subject to the Ownership Limitation (as defined herein).


Schedule 13G/A

CUSIP No. 28659T200 PAGE 24 OF 47

------------------------------------------------------------------------------
(1) NAME OF REPORTING PERSON
 S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
 Avram Z. Friedman
------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
 (a) [ ]
 (b) [X]

------------------------------------------------------------------------------
(3) SEC USE ONLY
------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
 United States
------------------------------------------------------------------------------
NUMBER OF (5) SOLE VOTING POWER
 0
SHARES ____________________________________________________________
BENEFICIALLY (6) SHARED VOTING POWER
 7,967 Series C 8% Preferred Stock convertible into
 3,434,052 Common Shares, Warrants exercisable into
 1,030,208 Common Shares and 2,108,249 Common Shares
OWNED BY ____________________________________________________________
EACH (7) SOLE DISPOSITIVE POWER
 0
REPORTING ____________________________________________________________
PERSON WITH (8) SHARED DISPOSITIVE POWER
 7,967 Series C 8% Preferred Stock convertible into
 3,434,052 Common Shares, Warrants exercisable into
 1,030,208 Common Shares and 2,108,249 Common Shares
------------------------------------------------------------------------------
 (9) AGGREGATE AMOUNT BENEFICIALLY OWNED
 BY EACH REPORTING PERSON
 7,967 Series C 8% Preferred Stock convertible into
 3,434,052 Common Shares, Warrants exercisable into
 1,030,208 Common Shares and 2,108,249 Common Shares
------------------------------------------------------------------------------
 (10) CHECK BOX IF THE AGGREGATE AMOUNT
 IN ROW (9) EXCLUDES CERTAIN SHARES [ ]
------------------------------------------------------------------------------
 (11) PERCENT OF CLASS REPRESENTED
 BY AMOUNT IN ROW (9)
 9.9%(10)
------------------------------------------------------------------------------
 (12) TYPE OF REPORTING PERSON
 IN
------------------------------------------------------------------------------

---------------------
(10) Subject to the Ownership Limitation (as defined herein).


Schedule 13G/A

CUSIP No. 28659T200 PAGE 25 OF 47

------------------------------------------------------------------------------
(1) NAME OF REPORTING PERSON
 S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
 Conor Bastable
------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
 (a) [ ]
 (b) [X]

------------------------------------------------------------------------------
(3) SEC USE ONLY
------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
 United States
------------------------------------------------------------------------------
NUMBER OF (5) SOLE VOTING POWER
 0
SHARES ____________________________________________________________
BENEFICIALLY (6) SHARED VOTING POWER
 7,967 Series C 8% Preferred Stock convertible into
 3,434,052 Common Shares, Warrants exercisable into
 1,030,208 Common Shares and 2,108,249 Common Shares
OWNED BY ____________________________________________________________
EACH (7) SOLE DISPOSITIVE POWER
 0
REPORTING ____________________________________________________________
PERSON WITH (8) SHARED DISPOSITIVE POWER
 7,967 Series C 8% Preferred Stock convertible into
 3,434,052 Common Shares, Warrants exercisable into
 1,030,208 Common Shares and 2,108,249 Common Shares
------------------------------------------------------------------------------
 (9) AGGREGATE AMOUNT BENEFICIALLY OWNED
 BY EACH REPORTING PERSON
 7,967 Series C 8% Preferred Stock convertible into
 3,434,052 Common Shares, Warrants exercisable into
 1,030,208 Common Shares and 2,108,249 Common Shares
------------------------------------------------------------------------------
 (10) CHECK BOX IF THE AGGREGATE AMOUNT
 IN ROW (9) EXCLUDES CERTAIN SHARES [ ]
------------------------------------------------------------------------------
 (11) PERCENT OF CLASS REPRESENTED
 BY AMOUNT IN ROW (9)
 9.9%(11)
------------------------------------------------------------------------------
 (12) TYPE OF REPORTING PERSON
 IN
------------------------------------------------------------------------------

---------------------
(11) Subject to the Ownership Limitation (as defined herein).


Schedule 13G/A

CUSIP No. 28659T200 PAGE 26 OF 47

------------------------------------------------------------------------------

ITEM 1(a). NAME OF ISSUER:

 Elite Pharmaceuticals, Inc. (the "Company")

ITEM 1(b). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES:

 165 Ludlow Avenue
 Northvale, NJ 07647

ITEM 2(a). NAME OF PERSON FILING:

 This Statement is filed by each of the entities and persons listed below,
all of whom together are referred to herein as the "Reporting Persons":

 (i) Davidson Kempner Partners, a New York limited
 partnership ("DKP");

 (ii) Davidson Kempner Institutional Partners, L.P., a
 Delaware limited partnership ("DKIP");

 (iii) M. H. Davidson & Co., a New York limited partnership
 ("CO");

 (iv) Davidson Kempner International, Ltd., a British
 Virgin Islands corporation ("DKIL");

 (v) Serena Limited, a Cayman Islands corporation ("Serena");

 (vi) Davidson Kempner Healthcare Fund LP, a Delaware
 limited partnership ("DKHF");

 (vii) Davidson Kempner Healthcare International Ltd., a
 Cayman Islands corporation ("DKHI");

 (viii) MHD Management Co., a New York limited partnership
 and the general partner of DKP ("MHD");

 (ix) Davidson Kempner Advisers Inc., a New York
 corporation and the general partner of DKIP ("DKAI"),
 which is registered as an investment adviser with the
 U.S. Securities and Exchange Commission;

 (x) Davidson Kempner International Advisors, L.L.C., a
 Delaware limited liability company and the manager of
 DKIL and Serena ("DKIA");

 (xi) DK Group LLC, a Delaware limited liability company
 and the general partner of DKHF ("DKG");

 (xii) DK Management Partners LP, a Delaware limited
 partnership and the investment manager of DKHI
 ("DKMP");


Schedule 13G/A

CUSIP No. 28659T200 PAGE 27 OF 47

 (xiii) DK Stillwater GP LLC, a Delaware limited liability
 company and the general partner of DKMP ("DKS"); and

 (xiv) Messrs. Thomas L. Kempner, Jr., Marvin H. Davidson,
 Stephen M. Dowicz, Scott E. Davidson, Michael J. Leffell,
 Timothy I. Levart, Robert J. Brivio, Jr., Anthony A.
 Yoseloff, Eric P. Epstein, Avram Z. Friedman and Conor
 Bastable (collectively, the "Principals"), who are the
 general partners of CO and MHD, the sole managing members
 of DKIA and DKG and the sole stockholders of DKAI. Messrs.
 Thomas L. Kempner, Jr. and Timothy I. Levart are Executive
 Managing Member and Deputy Executive Managing Member,
 respectively, of DKS. Each of Messrs. Kempner and Levart,
 together with Messrs. Marvin H. Davidson, Stephen
 M. Dowicz, Scott E. Davidson, Michael J. Leffell, Robert
 J. Brivio, Jr., Anthony A. Yoseloff, Eric P. Epstein,
 Avram Z. Friedman and Conor Bastable are limited partners
 of DKMP.

ITEM 2(b). ADDRESS OF PRINCIPAL BUSINESS OFFICE:

 The address of the principal business office of each of the Reporting
Persons is c/o Davidson Kempner Partners, 65 East 55th Street, 19th Floor, New
York, New York 10022.

ITEM 2(c). CITIZENSHIP:

 (i) DKP - a New York limited partnership

 (ii) DKIP - a Delaware limited partnership

 (iii) CO - a New York limited partnership

 (iv) DKIL - a British Virgin Islands corporation

 (v) Serena - a Cayman Islands corporation

 (vi) DKHF - a Delaware limited partnership

 (vii) DKHI - a Cayman Islands corporation

 (viii) MHD - a New York limited partnership

 (ix) DKAI - a New York corporation

 (x) DKIA - a Delaware limited liability company

 (xi) DKG - a Delaware limited liability company

 (xii) DKMP - a Delaware limited partnership

 (xiii) DKS - a Delaware limited liability company

 (xiv) Thomas L. Kempner, Jr. - United States

 (xv) Marvin H. Davidson - United States


Schedule 13G/A

CUSIP No. 28659T200 PAGE 28 OF 47

 (xvi) Stephen M. Dowicz - United States

 (xvii) Scott E. Davidson -United States

 (xviii) Michael J. Leffell - United States

 (xix) Timothy I. Levart - United Kingdom & United States

 (xx) Robert J. Brivio, Jr. - United States

 (xxi) Eric P. Epstein - United States

 (xxii) Anthony A. Yoseloff - United States

 (xxiii) Avram Z. Friedman - United States

 (xxiv) Conor Bastable - United States

ITEM 2(d). TITLE OF CLASS OF SECURITIES:

 COMMON STOCK, $0.01 PAR VALUE PER SHARE

ITEM 2(e). CUSIP NUMBER:

 28659T200

ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO 13d-1(b) OR 13d-2(b) OR (c),
CHECK WHETHER THE PERSON FILING IS A:

 (a)[ ] Broker or dealer registered under Section 15
 of the Act;

 (b)[ ] Bank as defined in Section 3(a)(6) of the
 Act;

 (c)[ ] Insurance Company as defined in Section
 3(a)(19) of the Act;

 (d)[ ] Investment Company registered under Section 8
 of the Investment Company Act of 1940;

 (e)[ ] Investment Adviser registered under Section 203 of the
 Investment Advisers Act of 1940: see Rule 13d-1(b)(1)(ii)
 E);

 (f)[ ] Employee Benefit Plan, Pension Fund which is
 subject to the provisions of the Employee
 Retirement Income Security Act of 1974 or
 Endowment Fund; see Rule 13d-1(b)(1)(ii)(F);

 (g)[ ] Parent Holding Company, in accordance with
 Rule 13d-1(b)(ii)(G);

 (h)[ ] Savings Associations as defined in Section
 3(b) of the Federal Deposit Insurance Act;


Schedule 13G/A

CUSIP No. 28659T200 PAGE 29 OF 47

 (i)[ ] Church Plan that is excluded from the
 definition of an investment company under Section
 3(c)(14) of the Investment Company Act of 1940;

 (j)[ ] Group, in accordance with Rule
 13d-1(b)(1)(ii)(J).

ITEM 4. OWNERSHIP.

 Subject to the Ownership Limitation (as defined below), the Principals may
be deemed to beneficially own an aggregate of 7,967 Series C 8% Preferred Stock
convertible into 3,434,052 Common Shares, Warrants exercisable into 1,030,208
Common Shares and 2,108,249 Common Shares as a result of their voting and
dispositive power over the 7,967 Series C 8% Preferred Stock convertible into
3,434,052 Common Shares, Warrants exercisable into 1,030,208 Common Shares and
2,108,249 Common Shares beneficially owned by DKP, DKIP, DKIL, CO, DKHF and
DKHI.

 DKIA may be deemed to beneficially own the 1,007 Series C 8% Preferred
Stock convertible into 434,052 Common Shares, Warrants exercisable into 130,213
Common Shares and 265,154 Common Shares beneficially owned by DKIL as a result
of its voting and dispositive power over those shares. DKAI may be deemed to
beneficially own the 560 Series C 8% Preferred Stock convertible into 241,379
Common Shares, Warrants exercisable into 72,412 Common Shares and 147,462 Common
Shares owned by DKIP as a result of its voting and dispositive power over those
shares. MHD may be deemed to beneficially own the 309 Series C 8% Preferred
Stock convertible into 133,190 Common Shares, Warrants exercisable into 39,956
Common Shares and 81,300 Common Shares beneficially owned by DKP as a result of
its voting and dispositive power over those shares. DKG may be deemed to
beneficially own the 2,449 Series C 8% Preferred Stock convertible into
1,055,603 Common Shares, Warrants exercisable into 316,680 Common Shares and
648,953 Common Shares beneficially owned by DKHF as a result of its voting and
dispositive power over those shares. DKMP and DKS may be deemed to beneficially
own the 3,602 Series C 8% Preferred Stock convertible into 1,552,586 Common
Shares, Warrants exercisable into Common Shares and 954,832 Common Shares
beneficially owned by DKHI as a result of their voting and dispositive power
over those shares.

 As set forth in the Certificate of Designation of Preferences, Rights and
Limitations of Series C 8% Convertible Preferred Stock and each Common Stock
Purchase Warrant held by the Reporting Persons, respectively, the number of
Common Shares into which the Preferred Stock are convertible and the Warrants
are exercisable is limited to that number of Common Shares which would result in
the Reporting Persons having aggregate beneficial ownership of not more than
9.99% of the total issued and outstanding shares of Common Shares (the
"Ownership Limitation").

 A. DKP

 (a) Amount beneficially owned: 309 Series C 8% Preferred Stock
 convertible into 133,190 Common Shares, Warrants exercisable into
 39,956 Common Shares and 81,300 Common Shares

 (b) Percent of class: 0.8%

 (c) Number of shares as to which such person has:


Schedule 13G/A

CUSIP No. 28659T200 PAGE 30 OF 47

 (i) sole power to vote or to direct the vote: 0

 (ii) shared power to vote or to direct the vote: 309
 Series C 8% Preferred Stock convertible into 133,190
 Common Shares, Warrants exercisable into 39,956 Common
 Shares and 81,300 Common Shares

 (iii) sole power to dispose or to direct the disposition: 0

 (iv) shared power to dispose or to direct the disposition:
 309 Series C 8% Preferred Stock convertible into 133,190
 Common Shares, Warrants exercisable into 39,956 Common
 Shares and 81,300 Common Shares

 B. DKIP

 (a) Amount beneficially owned: 560 Series C 8% Preferred Stock
 convertible into 241,379 Common Shares, Warrants exercisable
 into 72,412 Common Shares and 147,462 Common Shares

 (b) Percent of class: 1.4%

 (c) Number of shares as to which such person has:

 (i) sole power to vote or to direct the vote: 0

 (ii) shared power to vote or to direct the vote: 560
 Series C 8% Preferred Stock convertible into 241,379
 Common Shares, Warrants exercisable into 72,412 Common
 Shares and 147,462 Common Shares

 (iii) sole power to dispose or to direct the disposition: 0

 (iv) shared power to dispose or to direct the disposition:
 560 Series C 8% Preferred Stock convertible into 241,379
 Common Shares, Warrants exercisable into 72,412 Common
 Shares and 147,462 Common Shares

 C. CO

 (a) Amount beneficially owned: 40 Series C 8% Preferred Stock
 convertible into 17,241 Common Shares, Warrants exercisable
 into 5,172 Common Shares and 10,548 Common Shares

 (b) Percent of class: 0.1%

 (c) Number of shares as to which such person has:

 (i) sole power to vote or to direct the vote: 0

 (ii) shared power to vote or to direct the vote: 40 Series
 C 8% Preferred Stock convertible into 17,241 Common
 Shares, Warrants exercisable into 5,172 Common Shares
 and 10,548 Common Shares

 (iii) sole power to dispose or to direct the disposition: 0


Schedule 13G/A

CUSIP No. 28659T200 PAGE 31 OF 47

 (iv) shared power to dispose or to direct the disposition:
 40 Series C 8% Preferred Stock convertible into
 17,241 Common Shares, Warrants exercisable into
 5,172 Common Shares and 10,548 Common Shares

 D. DKIL

 (a) Amount beneficially owned: 1,007 Series C 8% Preferred Stock
 convertible into 434,052 Common Shares, Warrants exercisable into
 130,213 Common Shares and 265,154 Common Shares

 (b) Percent of class: 2.5%

 (c) Number of shares as to which such person has:

 (i) sole power to vote or to direct the vote: 0

 (ii) shared power to vote or to direct the vote: 1,007 Series
 C 8% Preferred Stock convertible into 434,052 Common Shares,
 Warrants exercisable into 130,213 Common Shares and 265,154
 Common Shares

 (iii) sole power to dispose or to direct the disposition: 0

 (iv) shared power to dispose or to direct the disposition: 1,007
 Series C 8% Preferred Stock convertible into 434,052 Common
 Shares, Warrants exercisable into 130,213 Common Shares and
 265,154 Common Shares

 E. Serena

 (a) Amount beneficially owned: 0

 (b) Percent of class: 0.0%

 (c) Number of shares as to which such person has:

 (i) sole power to vote or to direct the vote: 0

 (ii) shared power to vote or to direct the vote: 0

 (iii) sole power to dispose or to direct the disposition: 0

 (iv) shared power to dispose or to direct the disposition: 0

 F. DKHF

 (a) Amount beneficially owned: 2,449 Series C 8% Preferred Stock
 convertible into 1,055,603 Common Shares, Warrants exercisable
 into 316,680 Common Shares and 648,953 Common Shares

 (b) Percent of class: 6.0%

 (c) Number of shares as to which such person has:

 (i) sole power to vote or to direct the vote: 0

 (ii) shared power to vote or to direct the vote: 2,449
 Series C 8% Preferred Stock convertible into
 1,055,603 Common Shares, Warrants exercisable
 into 316,680 Common Shares and 648,953 Common Shares


Schedule 13G/A

CUSIP No. 28659T200 PAGE 32 OF 47


 (iii) sole power to dispose or to direct the disposition: 0

 (iv) shared power to dispose or to direct the disposition:
 2,449 Series C 8% Preferred Stock convertible into
 1,055,603 Common Shares, Warrants exercisable
 into 316,680 Common Shares and 648,953 Common Shares

 G. DKHI

 (a) Amount beneficially owned: 3,602 Series C 8% Preferred Stock
 convertible into 1,552,586 Common Shares, Warrants exercisable
 into 465,775 Common Shares and 954,832 Common Shares

 (b) Percent of class: 8.8%

 (c) Number of shares as to which such person has:

 (i) sole power to vote or to direct the vote: 0

 (ii) shared power to vote or to direct the vote: 3,602
 Series C 8% Preferred Stock convertible into
 1,552,586 Common Shares, Warrants exercisable
 into 465,775 Common Shares and 954,832 Common Shares

 (iii) sole power to dispose or to direct the disposition: 0

 (iv) shared power to dispose or to direct the disposition:
 3,602 Series C 8% Preferred Stock convertible into
 1,552,586 Common Shares, Warrants exercisable
 into 465,775 Common Shares and 954,832 Common Shares

 H. MHD

 (a) Amount beneficially owned: 309 Series C 8% Preferred Stock
 convertible into 133,190 Common Shares, Warrants exercisable
 into 39,956 Common Shares and 81,300 Common Shares

 (b) Percent of class: 0.8%

 (c) Number of shares as to which such person has:

 (i) sole power to vote or to direct the vote: 0

 (ii) shared power to vote or to direct the vote: 309
 Series C 8% Preferred Stock convertible into 133,190
 Common Shares, Warrants exercisable into 39,956
 Common Shares and 81,300 Common Shares

 (iii) sole power to dispose or to direct the disposition: 0

 (iv) shared power to dispose or to direct the disposition:
 309 Series C 8% Preferred Stock convertible into
 133,190 Common Shares, Warrants exercisable
 into 39,956 Common Shares and 81,300 Common Shares

 I. DKAI

 (a) Amount beneficially owned: 560 Series C 8% Preferred Stock
 convertible into 241,379 Common Shares, Warrants exercisable
 into 72,412 Common Shares and 147,462 Common Shares

 (b) Percent of class: 1.4%

 (c) Number of shares as to which such person has:


Schedule 13G/A

CUSIP No. 28659T200 PAGE 33 OF 47

 (i) sole power to vote or to direct the vote: 0

 (ii) shared power to vote or to direct the vote: 560
 Series C 8% Preferred Stock convertible into 241,379
 Common Shares, Warrants exercisable into 72,412
 Common Shares and 147,462 Common Shares

 (iii) sole power to dispose or to direct the disposition: 0

 (iv) shared power to dispose or to direct the disposition:
 560 Series C 8% Preferred Stock convertible into
 241,379 Common Shares, Warrants exercisable
 into 72,412 Common Shares and 147,462 Common Shares

 J. DKIA

 (a) Amount beneficially owned: 1,007 Series C 8% Preferred Stock
 convertible into 434,052 Common Shares, Warrants exercisable
 into 130,213 Common Shares and 265,154 Common Shares

 (b) Percent of class: 2.5%

 (c) Number of shares as to which such person has:

 (i) sole power to vote or to direct the vote: 0

 (ii) shared power to vote or to direct the vote: 1,007
 Series C 8% Preferred Stock convertible into 434,052
 Common Shares, Warrants exercisable into 130,213
 Common Shares and 265,154 Common Shares

 (iii) sole power to dispose or to direct the disposition: 0

 (iv) shared power to dispose or to direct the disposition:
 1,007 Series C 8% Preferred Stock convertible into
 434,052 Common Shares, Warrants exercisable
 into 130,213 Common Shares and 265,154 Common Shares

 K. DKG

 (a) Amount beneficially owned: 2,449 Series C 8% Preferred Stock
 convertible into 1,055,603 Common Shares, Warrants exercisable
 into 316,680 Common Shares and 648,953 Common Shares

 (b) Percent of class: 6.0%

 (c) Number of shares as to which such person has:

 (i) sole power to vote or to direct the vote: 0

 (ii) shared power to vote or to direct the vote: 2,449
 Series C 8% Preferred Stock convertible into
 1,055,603 Common Shares, Warrants exercisable
 into 316,680 Common Shares and 648,953 Common Shares

 (iii) sole power to dispose or to direct the disposition: 0


Schedule 13G/A

CUSIP No. 28659T200 PAGE 34 OF 47

 (iv) shared power to dispose or to direct the disposition:
 2,449 Series C 8% Preferred Stock convertible into
 1,055,603 Common Shares, Warrants exercisable
 into 316,680 Common Shares and 648,953 Common Shares

 L. DKMP

 (a) Amount beneficially owned: 3,602 Series C 8% Preferred Stock
 convertible into 1,552,586 Common Shares, Warrants exercisable
 into 465,775 Common Shares and 954,832 Common Shares

 (b) Percent of class: 8.8%

 (c) Number of shares as to which such person has:

 (i) sole power to vote or to direct the vote: 0

 (ii) shared power to vote or to direct the vote: 3,602
 Series C 8% Preferred Stock convertible into
 1,552,586 Common Shares, Warrants exercisable
 into 465,775 Common Shares and 954,832 Common Shares

 (iii) sole power to dispose or to direct the disposition: 0

 (iv) shared power to dispose or to direct the disposition:
 3,602 Series C 8% Preferred Stock convertible into
 1,552,586 Common Shares, Warrants exercisable into
 465,775 Common Shares and 954,832 Common Shares

 M. DKS

 (a) Amount beneficially owned: 3,602 Series C 8% Preferred Stock
 convertible into 1,552,586 Common Shares, Warrants exercisable
 into 465,775 Common Shares and 954,832 Common Shares

 (b) Percent of class: 8.8%

 (c) Number of shares as to which such person has:

 (i) sole power to vote or to direct the vote: 0

 (ii) shared power to vote or to direct the vote: 3,602
 Series C 8% Preferred Stock convertible into
 1,552,586 Common Shares, Warrants exercisable
 into 465,775 Common Shares and 954,832 Common Shares

 (iii) sole power to dispose or to direct the disposition: 0

 (iv) shared power to dispose or to direct the disposition:
 3,602 Series C 8% Preferred Stock convertible into
 1,552,586 Common Shares, Warrants exercisable
 into 465,775 Common Shares and 954,832 Common Shares


Schedule 13G/A

CUSIP No. 28659T200 PAGE 35 OF 47

 N. Thomas L. Kempner, Jr.

 (a) Amount beneficially owned: 7,967 Series C 8% Preferred Stock
 convertible into 3,434,052 Common Shares, Warrants exercisable
 into 1,030,208 Common Shares and 2,108,249 Common Shares

 (b) Percent of class: 9.9%(12)

 (c) Number of shares as to which such person has:

 (i) sole power to vote or to direct the vote: 0

 (ii) shared power to vote or to direct the vote: 7,967
 Series C 8% Preferred Stock convertible into
 3,434,052 Common Shares, Warrants exercisable into
 1,030,208 Common Shares and 2,108,249 Common Shares

 (iii) sole power to dispose or to direct the disposition: 0

 (iv) shared power to dispose or to direct the disposition:
 7,967 Series C 8% Preferred Stock convertible into
 3,434,052 Common Shares, Warrants exercisable into
 1,030,208 Common Shares and 2,108,249 Common Shares

 O. Marvin H. Davidson

 (a) Amount beneficially owned: 7,967 Series C 8% Preferred Stock
 convertible into 3,434,052 Common Shares, Warrants exercisable
 into 1,030,208 Common Shares and 2,108,249 Common Shares

 (b) Percent of class: 9.9%(13)

 (c) Number of shares as to which such person has:

 (i) sole power to vote or to direct the vote: 0

 (ii) shared power to vote or to direct the vote: 7,967
 Series C 8% Preferred Stock convertible into
 3,434,052 Common Shares, Warrants exercisable into
 1,030,208 Common Shares and 2,108,249 Common Shares

 (iii) sole power to dispose or to direct the disposition: 0

 (iv) shared power to dispose or to direct the disposition:
 7,967 Series C 8% Preferred Stock convertible into
 3,434,052 Common Shares, Warrants exercisable into
 1,030,208 Common Shares and 2,108,249 Common Shares

---------------------
(12) Subject to the Ownership Limitation (as defined herein).
(13) Subject to the Ownership Limitation (as defined herein).


Schedule 13G/A

CUSIP No. 28659T200 PAGE 36 OF 47

 P. Stephen M. Dowicz

 (a) Amount beneficially owned: 7,967 Series C 8% Preferred Stock
 convertible into 3,434,052 Common Shares, Warrants exercisable
 into 1,030,208 Common Shares and 2,108,249 Common Shares

 (b) Percent of class: 9.9%(14)

 (c) Number of shares as to which such person has:

 (i) sole power to vote or to direct the vote: 0

 (ii) shared power to vote or to direct the vote: 7,967
 Series C 8% Preferred Stock convertible into
 3,434,052 Common Shares, Warrants exercisable into
 1,030,208 Common Shares and 2,108,249 Common Shares

 (iii) sole power to dispose or to direct the disposition: 0

 (iv) shared power to dispose or to direct the disposition:
 7,967 Series C 8% Preferred Stock convertible into
 3,434,052 Common Shares, Warrants exercisable into
 1,030,208 Common Shares and 2,108,249 Common Shares

 Q. Scott E. Davidson

 (a) Amount beneficially owned: 7,967 Series C 8% Preferred Stock
 convertible into 3,434,052 Common Shares, Warrants exercisable
 into 1,030,208 Common Shares and 2,108,249 Common Shares

 (b) Percent of class: 9.9%(15)

 (c) Number of shares as to which such person has:

 (i) sole power to vote or to direct the vote: 0

 (ii) shared power to vote or to direct the vote: 7,967
 Series C 8% Preferred Stock convertible into
 3,434,052 Common Shares, Warrants exercisable into
 1,030,208 Common Shares and 2,108,249 Common Shares

 (iii) sole power to dispose or to direct the disposition: 0

 (iv) shared power to dispose or to direct the disposition:
 7,967 Series C 8% Preferred Stock convertible into
 3,434,052 Common Shares, Warrants exercisable into
 1,030,208 Common Shares and 2,108,249 Common Shares

---------------------
(14) Subject to the Ownership Limitation (as defined herein).
(15) Subject to the Ownership Limitation (as defined herein).


Schedule 13G/A

CUSIP No. 28659T200 PAGE 37 OF 47

 R. Michael J. Leffell

 (a) Amount beneficially owned. 7,967 Series C 8% Preferred Stock
 convertible into 3,434,052 Common Shares, Warrants exercisable
 into 1,030,208 Common Shares and 2,108,249 Common Shares

 (b) Percent of class: 9.9%(16)

 (c) Number of shares as to which such person has:

 (i) sole power to vote or to direct the vote: 0

 (ii) shared power to vote or to direct the vote: 7,967
 Series C 8% Preferred Stock convertible into
 3,434,052 Common Shares, Warrants exercisable into
 1,030,208 Common Shares and 2,108,249 Common Shares

 (iii) sole power to dispose or to direct the disposition: 0

 (iv) shared power to dispose or to direct the disposition:
 7,967 Series C 8% Preferred Stock convertible into
 3,434,052 Common Shares, Warrants exercisable into
 1,030,208 Common Shares and 2,108,249 Common Shares

 S. Timothy I. Levart

 (a) Amount beneficially owned: 7,967 Series C 8% Preferred Stock
 convertible into 3,434,052 Common Shares, Warrants exercisable
 into 1,030,208 Common Shares and 2,108,249 Common Shares

 (b) Percent of class: 9.9%(17)

 (c) Number of shares as to which such person has:

 (i) sole power to vote or to direct the vote: 0

 (ii) shared power to vote or to direct the vote: 7,967
 Series C 8% Preferred Stock convertible into
 3,434,052 Common Shares, Warrants exercisable into
 1,030,208 Common Shares and 2,108,249 Common Shares

 (iii) sole power to dispose or to direct the disposition: 0

 (iv) shared power to dispose or to direct the disposition:
 7,967 Series C 8% Preferred Stock convertible into
 3,434,052 Common Shares, Warrants exercisable into
 1,030,208 Common Shares and 2,108,249 Common Shares

---------------------
(16) Subject to the Ownership Limitation (as defined herein).
(17) Subject to the Ownership Limitation (as defined herein).


Schedule 13G/A

CUSIP No. 28659T200 PAGE 38 OF 47

 T. Robert J. Brivio, Jr.

 (a) Amount beneficially owned: 7,967 Series C 8% Preferred Stock
 convertible into 3,434,052 Common Shares, Warrants exercisable
 into 1,030,208 Common Shares and 2,108,249 Common Shares

 (b) Percent of class: 9.9%(18)

 (c) Number of shares as to which such person has:

 (i) sole power to vote or to direct the vote: 0

 (ii) shared power to vote or to direct the vote: 7,967
 Series C 8% Preferred Stock convertible into
 3,434,052 Common Shares, Warrants exercisable into
 1,030,208 Common Shares and 2,108,249 Common Shares

 (iii) sole power to dispose or to direct the disposition: 0

 (iv) shared power to dispose or to direct the disposition:
 7,967 Series C 8% Preferred Stock convertible into
 3,434,052 Common Shares, Warrants exercisable into
 1,030,208 Common Shares and 2,108,249 Common Shares

 U. Eric P. Epstein

 (a) Amount beneficially owned: 7,967 Series C 8% Preferred Stock
 convertible into 3,434,052 Common Shares, Warrants exercisable
 into 1,030,208 Common Shares and 2,108,249 Common Shares

 (b) Percent of class: 9.9%(19)

 (c) Number of shares as to which such person has:

 (i) sole power to vote or to direct the vote: 0

 (ii) shared power to vote or to direct the vote: 7,967
 Series C 8% Preferred Stock convertible into
 3,434,052 Common Shares, Warrants exercisable into
 1,030,208 Common Shares and 2,108,249 Common Shares

 (iii) sole power to dispose or to direct the disposition: 0

 (iv) shared power to dispose or to direct the disposition:
 7,967 Series C 8% Preferred Stock convertible into
 3,434,052 Common Shares, Warrants exercisable into
 1,030,208 Common Shares and 2,108,249 Common Shares

---------------------
(18) Subject to the Ownership Limitation (as defined herein).
(19) Subject to the Ownership Limitation (as defined herein).


Schedule 13G/A

CUSIP No. 28659T200 PAGE 39 OF 47

 V. Anthony A. Yoseloff

 (a) Amount beneficially owned: 7,967 Series C 8% Preferred Stock
 convertible into 3,434,052 Common Shares, Warrants exercisable
 into 1,030,208 Common Shares and 2,108,249 Common Shares

 (b) Percent of class: 9.9%(20)

 (c) Number of shares as to which such person has:

 (i) sole power to vote or to direct the vote: 0

 (ii) shared power to vote or to direct the vote: 7,967
 Series C 8% Preferred Stock convertible into
 3,434,052 Common Shares, Warrants exercisable into
 1,030,208 Common Shares and 2,108,249 Common Shares

 (iii) sole power to dispose or to direct the disposition: 0

 (iv) shared power to dispose or to direct the disposition:
 7,967 Series C 8% Preferred Stock convertible into
 3,434,052 Common Shares, Warrants exercisable into
 1,030,208 Common Shares and 2,108,249 Common Shares

 W. Avram Z. Friedman

 (a) Amount beneficially owned: 7,967 Series C 8% Preferred Stock
 convertible into 3,434,052 Common Shares, Warrants exercisable
 into 1,030,208 Common Shares and 2,108,249 Common Shares

 (b) Percent of class: 9.9%(21)

 (c) Number of shares as to which such person has:

 (i) sole power to vote or to direct the vote: 0

 (ii) shared power to vote or to direct the vote: 7,967
 Series C 8% Preferred Stock convertible into
 3,434,052 Common Shares, Warrants exercisable into
 1,030,208 Common Shares and 2,108,249 Common Shares

 (iii) sole power to dispose or to direct the disposition: 0

 (iv) shared power to dispose or to direct the disposition:
 7,967 Series C 8% Preferred Stock convertible into
 3,434,052 Common Shares, Warrants exercisable into
 1,030,208 Common Shares and 2,108,249 Common Shares

---------------------
(20) Subject to the Ownership Limitation (as defined herein).
(21) Subject to the Ownership Limitation (as defined herein).


Schedule 13G/A

CUSIP No. 28659T200 PAGE 40 OF 47

 X. Conor Bastable

 (a) Amount beneficially owned: 7,967 Series C 8% Preferred Stock
 convertible into 3,434,052 Common Shares, Warrants exercisable
 into 1,030,208 Common Shares and 2,108,249 Common Shares

 (b) Percent of class: 9.9%(21)

 (c) Number of shares as to which such person has:

 (i) sole power to vote or to direct the vote: 0

 (ii) shared power to vote or to direct the vote: 7,967
 Series C 8% Preferred Stock convertible into
 3,434,052 Common Shares, Warrants exercisable into
 1,030,208 Common Shares and 2,108,249 Common Shares

 (iii) sole power to dispose or to direct the disposition: 0

 (iv) shared power to dispose or to direct the disposition:
 7,967 Series C 8% Preferred Stock convertible into
 3,434,052 Common Shares, Warrants exercisable into
 1,030,208 Common Shares and 2,108,249 Common Shares

ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS.

 Not applicable.

ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON.

 The partners, members or stockholders of each of the Reporting Persons,
including the Principals, have the right to participate in the receipt of
dividends from, or proceeds from the sale of, the securities held for the
account of such Reporting Person in accordance with their ownership interests in
such Reporting Person. The Reporting Persons disclaim all beneficial ownership
as affiliates of a registered investment adviser, and, in any case, disclaim
beneficial ownership except as to the extent of their pecuniary interest in the
shares. The Reporting Persons have elected to file Schedule 13G although such
filing may not be required under the Act.

ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE
 SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY.

 Not applicable.

ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP.

 See Item 4.

---------------------
(22) Subject to the Ownership Limitation (as defined herein).


Schedule 13G/A

CUSIP No. 28659T200 PAGE 41 OF 47

ITEM 9. NOTICE OF DISSOLUTION OF GROUP.

 Not applicable.

ITEM 10. CERTIFICATION. (if filing pursuant to Rule 13d-1(c))

 Each of the Reporting Persons hereby makes the following certification:

 By signing below we certify that, to the best of our knowledge and belief,
the securities referred to above were not acquired and are not held for the
purpose of or with the effect of changing or influencing the control of the
issuer of the securities and were not acquired and are not held in connection
with or as a participant in any transaction having that purpose or effect.


Schedule 13G/A

CUSIP No. 28659T200 PAGE 42 OF 47


 SIGNATURES

 After reasonable inquiry and to the best of our knowledge and belief, the
undersigned certify that the information set forth in this statement is true,
complete and correct.

DATED: February 17, 2009 DAVIDSON KEMPNER PARTNERS
 By: MHD Management Co.,
 its General Partner

 /s/ Thomas L. Kempner, Jr.
 --------------------------
 Name: Thomas L. Kempner, Jr.
 Title: Managing Partner

 DAVIDSON KEMPNER INSTITUTIONAL
 PARTNERS, L.P.
 By: Davidson Kempner Advisers Inc.,
 its General Partner

 /s/ Thomas L. Kempner, Jr.
 --------------------------
 Name: Thomas L. Kempner, Jr.
 Title: President

 M.H. DAVIDSON & CO.

 /s/ Thomas L. Kempner, Jr.
 --------------------------
 Name: Thomas L. Kempner, Jr.
 Title: Managing Partner

 DAVIDSON KEMPNER INTERNATIONAL, LTD.
 By: Davidson Kempner International
 Advisors, L.L.C.,
 its Investment Manager

 /s/ Thomas L. Kempner, Jr.
 --------------------------
 Name: Thomas L. Kempner, Jr.
 Title: Executive Managing Member

 SERENA LIMITED
 By: Davidson Kempner International
 Advisors, L.L.C.,
 its Investment Manager

 /s/ Thomas L. Kempner, Jr.
 --------------------------
 Name: Thomas L. Kempner, Jr.
 Title: Executive Managing Member


Schedule 13G/A

CUSIP No. 28659T200 PAGE 43 OF 47


 DAVIDSON KEMPNER HEALTHCARE FUND LP
 By: DK Group LLC,
 its General Partner

 /s/ Thomas L. Kempner, Jr.
 --------------------------
 Name: Thomas L. Kempner, Jr.
 Title: Executive Managing Member

 DAVIDSON KEMPNER HEALTHCARE
 INTERNATIONAL LTD.
 By: DK Management Partners LP,
 its Investment Manager
 By: DK Stillwater GP LLC, its
 general partner

 /s/ Thomas L. Kempner, Jr.
 --------------------------
 Name: Thomas L. Kempner, Jr.
 Title: Executive Managing Member

 MHD MANAGEMENT CO.

 /s/ Thomas L. Kempner, Jr.
 --------------------------
 Name: Thomas L. Kempner, Jr.
 Title: Managing Partner

 DAVIDSON KEMPNER ADVISERS INC.

 /s/ Thomas L. Kempner, Jr.
 --------------------------
 Name: Thomas L. Kempner, Jr.
 Title: President

 DAVIDSON KEMPNER INTERNATIONAL
 ADVISORS, L.L.C.

 /s/ Thomas L. Kempner, Jr.
 --------------------------
 Name: Thomas L. Kempner, Jr.
 Title: Executive Managing Member

 DK GROUP LLC

 /s/ Thomas L. Kempner, Jr.
 --------------------------
 Name: Thomas L. Kempner, Jr.
 Title: Executive Managing Member


Schedule 13G/A

CUSIP No. 28659T200 PAGE 44 OF 47


 DK MANAGEMENT PARTNERS LP
 By: DK Stillwater GP LLC, its
 general partner

 /s/ Thomas L. Kempner, Jr.
 --------------------------
 Name: Thomas L. Kempner, Jr.
 Title: Executive Managing Member

 DK STILLWATER GP LLC

 /s/ Thomas L. Kempner, Jr.
 --------------------------
 Name: Thomas L. Kempner, Jr.
 Title: Executive Managing Member

 /s/ Thomas L. Kempner, Jr.
 --------------------------
 Thomas L. Kempner, Jr.

 /s/ Marvin H. Davidson
 --------------------------
 Marvin H. Davidson

 /s/ Stephen M. Dowicz
 --------------------------
 Stephen M. Dowicz

 /s/ Scott E. Davidson
 --------------------------
 Scott E. Davidson

 /s/ Michael J. Leffell
 --------------------------
 Michael J. Leffell

 /s/ Timothy I. Levart
 --------------------------
 Timothy I. Levart

 /s/ Robert J. Brivio, Jr.
 -------------------------
 Robert J. Brivio, Jr.

 /s/ Eric P. Epstein
 -------------------------
 Eric P. Epstein

 /s/ Anthony A. Yoseloff
 -------------------------
 Anthony A. Yoseloff

 /s/ Avram Z. Friedman
 -------------------------
 Avram Z. Friedman

 /s/ Conor Bastable
 -------------------------
 Conor Bastable


Schedule 13G/A

CUSIP No. 28659T200 PAGE 45 OF 47
 EXHIBIT 1

 JOINT ACQUISITION STATEMENT

 PURSUANT TO RULE 13d-1(k)

 The undersigned acknowledge and agree that the foregoing statement on
Schedule 13G is filed on behalf of each of the undersigned and that all
subsequent amendments to this statement on Schedule 13G, shall be filed on
behalf of each of the undersigned without the necessity of filing additional
joint acquisition statements. The undersigned acknowledge that each shall be
responsible for the timely filing of such amendments, and for the completeness
and accuracy of the information concerning him or it contained therein, but
shall not be responsible for the completeness and accuracy of the information
concerning the others, except to the extent that he or it knows or has reason to
believe that such information is inaccurate.

DATED: February 17, 2009 DAVIDSON KEMPNER PARTNERS
 By: MHD Management Co.,
 its General Partner

 /s/ Thomas L. Kempner, Jr.
 --------------------------
 Name: Thomas L. Kempner, Jr.
 Title: Managing Partner

 DAVIDSON KEMPNER INSTITUTIONAL PARTNERS,
 L.P.
 By: Davidson Kempner Advisers Inc.,
 its General Partner

 /s/ Thomas L. Kempner, Jr.
 --------------------------
 Name: Thomas L. Kempner, Jr.
 Title: President

 M.H. DAVIDSON & CO.

 /s/ Thomas L. Kempner, Jr.
 --------------------------
 Name: Thomas L. Kempner, Jr.
 Title: Managing Partner

 DAVIDSON KEMPNER INTERNATIONAL, LTD.
 By: Davidson Kempner International
 Advisors, L.L.C.,
 its Investment Manager

 /s/ Thomas L. Kempner, Jr.
 --------------------------
 Name: Thomas L. Kempner, Jr.
 Title: Executive Managing Member


Schedule 13G/A

CUSIP No. 28659T200 PAGE 46 OF 47


 SERENA LIMITED
 By: Davidson Kempner International
 Advisors, L.L.C.,
 its Investment Manager

 /s/ Thomas L. Kempner, Jr.
 --------------------------
 Name: Thomas L. Kempner, Jr.
 Title: Executive Managing Member

 DAVIDSON KEMPNER HEALTHCARE FUND LP
 By: DK Group LLC,
 its General Partner

 /s/ Thomas L. Kempner, Jr.
 --------------------------
 Name: Thomas L. Kempner, Jr.
 Title: Executive Managing Member

 DAVIDSON KEMPNER HEALTHCARE
 INTERNATIONAL LTD.
 By: DK Management Partners LP,
 its Investment Manager
 By: DK Stillwater GP LLC, its general
 partner

 /s/ Thomas L. Kempner, Jr.
 --------------------------
 Name: Thomas L. Kempner, Jr.
 Title: Executive Managing Member

 MHD MANAGEMENT CO.

 /s/ Thomas L. Kempner, Jr.
 --------------------------
 Name: Thomas L. Kempner, Jr.
 Title: Managing Partner

 DAVIDSON KEMPNER ADVISERS INC.

 /s/ Thomas L. Kempner, Jr.
 --------------------------
 Name: Thomas L. Kempner, Jr.
 Title: President

 DAVIDSON KEMPNER INTERNATIONAL ADVISORS,
 L.L.C.

 /s/ Thomas L. Kempner, Jr.
 --------------------------
 Name: Thomas L. Kempner, Jr.
 Title: Executive Managing Member


Schedule 13G/A

CUSIP No. 28659T200 PAGE 47 OF 47

 DK GROUP LLC

 /s/ Thomas L. Kempner, Jr.
 --------------------------
 Name: Thomas L. Kempner, Jr.
 Title: Executive Managing Member

 DK MANAGEMENT PARTNERS LP
 By: DK Stillwater GP LLC, its general
 partner

 /s/ Thomas L. Kempner, Jr.
 --------------------------
 Name: Thomas L. Kempner, Jr.
 Title: Executive Managing Member

 DK STILLWATER GP LLC

 /s/ Thomas L. Kempner, Jr.
 --------------------------
 Name: Thomas L. Kempner, Jr.
 Title: Executive Managing Member

 /s/ Thomas L. Kempner, Jr.
 --------------------------
 Thomas L. Kempner, Jr.

 /s/ Marvin H. Davidson
 --------------------------
 Marvin H. Davidson

 /s/ Stephen M. Dowicz
 --------------------------
 Stephen M. Dowicz

 /s/ Scott E. Davidson
 --------------------------
 Scott E. Davidson

 /s/ Michael J. Leffell
 --------------------------
 Michael J. Leffell

 /s/ Timothy I. Levart
 --------------------------
 Timothy I. Levart

 /s/ Robert J. Brivio, Jr.
 -------------------------
 Robert J. Brivio, Jr.

 /s/ Eric P. Epstein
 --------------------------
 Eric P. Epstein

 /s/ Anthony A. Yoseloff
 --------------------------
 Anthony A. Yoseloff

 /s/ Avram Z. Friedman
 --------------------------
 Avram Z. Friedman

 /s/ Conor Bastable
 --------------------------
 Conor Bastable

Elite Pharmaceuticals (AMEX:ELI)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Elite Pharmaceuticals Charts.
Elite Pharmaceuticals (AMEX:ELI)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Elite Pharmaceuticals Charts.